Oman vs Serbia: HIV-positive TB patients on ART (antiretroviral therapy)
Oman
100.0%
in 2024
Serbia
100.0%
in 2024
Oman rank
1st
Serbia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Oman
- Serbia
How they compare
Oman currently reports 100.0% against 100.0% in Serbia, a difference of 0.0%.
Across all 17 years both countries report, Serbia has been ahead every year.
Oman ranks 1st and Serbia ranks 1st of 144 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 93.1% | 100.0% | 6.9% | Serbia |
| 2020s | 85.5% | 100.0% | 14.5% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Oman or Serbia?
- Oman, at 100.0% against 100.0% in Serbia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Oman and Serbia?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Serbia?
- 17 years are reported by both, from 2005 to 2024.
- How do Oman and Serbia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Oman ranks 1st and Serbia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.